SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-190953
Filing Date
2022-07-11
Accepted
2022-07-11 08:53:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d314814d424b5.htm 424B5 381128
2 GRAPHIC g314814g55v98.jpg GRAPHIC 40584
3 GRAPHIC g314814g75r68.jpg GRAPHIC 65063
4 GRAPHIC g314814g76w82.jpg GRAPHIC 66902
  Complete submission text file 0001193125-22-190953.txt   614036
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255837 | Film No.: 221075958
SIC: 2836 Biological Products, (No Diagnostic Substances)